Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Japanese Journal of Complementary and Alternative Medicine ; : 25-28, 2023.
Article Dans Japonais | WPRIM | ID: wpr-1007153

Résumé

We reported 2 cases of plantar keratosis (59 years of age, female/39 years of age, male) successfully improved by intake of hot water extract of Coix lacryma-jobi L. var. ma-yuen Stapf with Husks. Both subjects were administered coix seed extract containing food for 20 weeks. The lesions improved gradually after 12 weeks, and almost cured by 20 weeks of administration. Although the food seemed to be effective in these cases, further studies are needed to define the optimal dose and duration.

2.
Chinese Journal of Medical Instrumentation ; (6): 530-535, 2021.
Article Dans Chinois | WPRIM | ID: wpr-922052

Résumé

There are five-year transitional period for manufacturers after the issue of regulation(EU) 2017/746 on


Sujets)
Union européenne , Marketing , Trousses de réactifs pour diagnostic
3.
Chinese Journal of Medical Instrumentation ; (6): 545-548, 2020.
Article Dans Chinois | WPRIM | ID: wpr-880408

Résumé

OBJECTIVE@#By introducing the Medical Device Reporting (MDR) system and related inspection practice of the US, this paper puts forward some suggestions on implementing reporting responsibility of manufactures in China.@*METHODS@#The MDR system and the related inspection system in the US were systematically analyzed.@*RESULTS@#The US had established a sound system for discovering and reporting MDR, and a mechanism for inspecting the implementing of manufactures, forming an effective post-market surveillance system.@*CONCLUSIONS@#By learning from the experience of the US, we can carry out the post-market surveillance of medical devices adverse events in China from the aspects of implementing the existing system, strengthening the reporting ability and perfecting the inspection mechanism.


Sujets)
Chine , Équipement et fournitures/normes , Surveillance post-commercialisation des produits de santé
SÉLECTION CITATIONS
Détails de la recherche